Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Nutra Pharma Corp. Stock Analysis NPHC
United States Health Care Nano Cap Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Plantation, Florida and currently employs 6 full-time employees. The company went IPO on 2001-10-09. The firm's drug candidates include RPI-MN and RPI-78M. RPI-MN is used to treat neurological diseases and autoimmune diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease), Rheumatoid Arthritis (RA) and Myasthenia Gravis. The RPI-78M is used to treat viral diseases, including HIV/AIDS and Herpes. The firm offers Nyloxin/Nyloxin Extra Strength as its over-the-counter (OTC) pain reliever. The company is focused upon marketing homeopathic drugs for the treatment of pain: Nyloxin, Nyloxin Extra Strength Pet Pain, Equine Pain, and Luxury Feet.
Read More Nutra Pharma Corp (NPHC) Chart
Key Statistics of Nutra Pharma Corp (NPHC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1000.00P/E Ratio (TTM)
-52 Week Range
Market Cap
715.97KAvg. Volume
1.08MDividend Yield
-Financial Metrics & Statements of Nutra Pharma Corp (NPHC)
FAQ's for Nutra Pharma Corp (NPHC)
- According to Musaffa’s Shariah screening methodology, Nutra Pharma Corp (NPHC) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nutra Pharma Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nutra Pharma Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nutra Pharma Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nutra Pharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nutra Pharma Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.